Ghandourh W; Dowling J; Chlap P; Oar A; Jacob S; Batumalai V; Holloway L, 2021, 'Assessing tumor centrality in lung stereotactic ablative body radiotherapy (SABR): the effects of variations in bronchial tree delineation and potential for automated methods', Medical Dosimetry, vol. 46, pp. 94 - 101, http://dx.doi.org/10.1016/j.meddos.2020.09.004
Perera SK; Jacob S; Wilson BE; Ferlay J; Bray F; Sullivan R; Barton M, 2021, 'Global demand for cancer surgery and an estimate of the optimal surgical and anaesthesia workforce between 2018 and 2040: a population-based modelling study', The Lancet Oncology, vol. 22, pp. 182 - 189, http://dx.doi.org/10.1016/S1470-2045(20)30675-6
Perera SK; Jacob S; Sullivan R; Barton M, 2021, 'Evidence-based benchmarks for use of cancer surgery in high-income countries: a population-based analysis', The Lancet Oncology, vol. 22, pp. 173 - 181, http://dx.doi.org/10.1016/S1470-2045(20)30589-1
Jacob SA; Do V; Wilson BE; Ng WL; Barton MB, 2021, 'The value of first-line chemotherapy and targeted therapy in the treatment of breast cancer', European Journal of Cancer Care, vol. 30, http://dx.doi.org/10.1111/ecc.13352
Wilson BE; Jacob S; Yap ML; Ferlay J; Bray F; Barton MB, 2019, 'Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study', The Lancet Oncology, vol. 20, pp. 769 - 780, http://dx.doi.org/10.1016/S1470-2045(19)30163-9
Thompson SR; Delaney GP; Jacob S; Shafiq J; Wong K; Hanna TP; Gabriel GS; Barton MB, 2016, 'Estimation of the optimal utilisation rates of radical prostatectomy, external beam radiotherapy and brachytherapy in the treatment of prostate cancer by a review of clinical practice guidelines', Radiotherapy and Oncology, vol. 118, pp. 118 - 121, http://dx.doi.org/10.1016/j.radonc.2015.12.023
Jacob SA; Ng WL; Do V, 2015, 'Estimation of an Optimal Chemotherapy Utilisation Rate for Cancer: Setting an Evidence-based Benchmark for Quality Cancer Care', Clinical Oncology, vol. 27, pp. 77 - 82, http://dx.doi.org/10.1016/j.clon.2014.10.004
Ng W; Jacob S; Delaney G; Do V; Barton M, 2015, 'Estimation of an optimal chemotherapy utilisation rate for upper gastrointestinal cancers: Setting an evidence-based benchmark for the best-quality cancer care', Gastroenterology Research and Practice, vol. 2015, http://dx.doi.org/10.1155/2015/753480
Barton MB; Jacob S; Shafiq J; Wong K; Thompson SR; Hanna TP; Delaney GP, 2014, 'Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012', Radiotherapy and Oncology, vol. 112, pp. 140 - 144, http://dx.doi.org/10.1016/j.radonc.2014.03.024
Thompson SR; Delaney GP; Gabriel GS; Jacob S; Barton MB, 2012, 'Estimation of the optimal brachytherapy utilisation rate in the treatment of vaginal cancer and comparison with patterns of care', Journal of medical imaging & radiation oncology, vol. 56, pp. 483 - 489, http://dx.doi.org/10.1111/j.1754-9485.2012.02392.x
Shafiq J; Saunders C; Thompson A; Tyldesley S; Olivotto IA; Barton MB; Dewar J; Ng W; Speers CH; Delaney GP, 2012, 'A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of “optimal” therapy', Breast, vol. 21, pp. 562 - 569, http://dx.doi.org/10.1016/j.breast.2012.01.006
Simunovic M; Jacob S; Coates AJ; Vogt K; Moran BJ; Heald RJ, 2011, 'Outcomes following a limited approach to radiotherapy in rectal cancer', British Journal of Surgery, vol. 98, pp. 1483 - 1488, http://dx.doi.org/10.1002/bjs.7560
Jacob S; Ng W; Delaney GP; Barton MB, 2011, 'Estimation of an Optimal Chemotherapy Utilisation Rate for Primary Malignant Brain Tumours: an Evidence-based Benchmark for Cancer Care', CLINICAL ONCOLOGY, vol. 23, pp. 48 - 54, http://dx.doi.org/10.1016/j.clon.2010.08.011
Jacob SA; Ng W; Asghari R; Delaney GP; Barton MB, 2011, 'Chemotherapy in rectal cancer: variation in utilization and development of an evidencebased benchmark rate of optimal chemotherapy utilization', Clinical Colorectal Cancer, vol. 10, pp. 102 - 107, http://dx.doi.org/10.1016/j.clcc.2011.03.005
Jacob SA; Ng W; Delaney GP; Barton MB, 2011, 'Estimation of an optimal chemotherapy utilisation rate for primary malignant brain tumours: an evidence-based benchmark for cancer care', Clinical Oncology, vol. 23, pp. 48 - 54, http://dx.doi.org/10.1016/j.clon.2010.08.011
Fong A; Shafiq J; Saunders C; Thompson A; Tyldesley S; Barton MB; Dewar JA; Ng W; Jacob S; Speers C; Olivotto I; Delaney GP, 2010, 'A Comparison of Breast Cancer Treatment Rates in British Columbia, Scotland, and Western Australia, and a Comparison with Models of "Optimal" Therapy', CANCER RESEARCH, vol. 70, http://dx.doi.org/10.1158/0008-5472.SABCS10-123-11-11
Ng W; Jacob SA; Delaney GP; Barton MB, 2010, 'Chemotherapy in Head and Neck Cancers: Summary of Recommendations and a Critical Review of Clinical Practice Guidelines', The European Journal of Clinical and Medical Oncology, vol. 2, pp. 65 - 71
Ng W; Delaney GP; Jacob SA; Barton MB, 2010, 'Estimation of an optimal chemotherapy utilisation rate for breast cancer: Setting an evidence-based benchmark for the best quality cancer care.', European Journal of Cancer, vol. 46, pp. 703 - 712, http://dx.doi.org/10.1016/j.ejca.2009.12.002
Jacob SA; Wong K; Delaney GP; Adams P; Barton MB, 2010, 'Estimation of an optimal utilisation rate for palliative radiotherapy in newly diagnosed cancer patients', Clinical Oncology, vol. 22, pp. 56 - 64, http://dx.doi.org/10.1016/j.clon.2009.11.003
Jacobs S; Ng W; Ashgari R; Delaney GP; Barton MB, 2009, 'Estimation of an optimal chemotherapy utilisation rate for colon cancer: an evidence-based benchmark for cancer care', European Journal of Cancer, vol. 45, pp. 2503 - 2509, http://dx.doi.org/10.1016/j.ejca.2009.05.023
Thompson SR; Delaney GP; Gabriel GS; Jacob SA; Das P; Barton MB, 2008, 'Estimation of optimal brachytherapy utilization rate in the treatment of malignancies of the uterine corpus by a review of clinical practice guidelines and the primary evidence', International Journal of Radiation Oncology and Biology Physics, vol. 72, pp. 849 - 858, http://dx.doi.org/10.1016/j.ijrobp.2008.01.022
Thompson S; Delaney G; Gabriel GS; Jacob S; Das P; Barton M, 2006, 'Estimation of the optimal brachytherapy utilization rate in the treatment of carcinoma of the uterine cervix: Review of clinical practice guidelines and primary evidence', Cancer, vol. 107, pp. 2932 - 2941, http://dx.doi.org/10.1002/cncr.22337
Delaney G; Barton M; Jacob S, 2006, 'Erratum: Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: A review of the evidence (Cancer (2004) 101, 4 (657-660))', Cancer, vol. 107, pp. 660, http://dx.doi.org/10.1002/cncr.22056
Delaney G; Jacob S; Featherstone C; Barton M, 2006, 'Erratum: The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence-based clinical guidelines (Cancer (2005) 101, 6 (1129-1137))', Cancer, vol. 107, pp. 660, http://dx.doi.org/10.1002/cncr.22057
Thompson SR; Delaney GP; Gabriel GS; Jacobs S; Das P; Barton MB, 2006, 'Estimation of the optimal brachytherapy utilization rate in the treatment of carcinoma in the uterine cervix', Cancer, vol. 107, pp. 2932 - 2941
Delaney GP; Jacobs S; Barton MB, 2006, 'Estimating the optimal radiotherapy utilisation for cancer of the central nervous system, thyroid cancer and cancer of unknown primary origin from evidence-based clinical guidelines', Cancer, vol. 106, pp. 453 - 465, http://dx.doi.org/10.1002/cncr.21596
Delaney GP; Jacob SA; Featherstone C; Barton MB, 2006, 'Estimating the Optimal Radiotherapy Utilization Rate Based on Clinical Guidelines and Best Available Evidence and Comparing it to Current Practice', Radiotherapy and Oncology, vol. 80, pp. S2 - S2, http://dx.doi.org/10.1016/S0167-8140(06)80746-2
Delaney GP; Jacob S; Featherstone C; Barton MB, 2005, 'The role of radiotherapy in cancer treatment - Estimating optimal utilization from a review of evidence-based clinical guidelines', Cancer, vol. 104, pp. 1129 - 1137, http://dx.doi.org/10.1002/cncr.21324
Delaney GP; Barton MB; Featherstone C; Jacobs S, 2005, 'Estimating the optimal utilisation rates of radiotherapy for hematologic malignancies from a review of the evidence. Part II - Leukaemia and Myelanoma', Cancer, vol. 103, pp. 393 - 401, http://dx.doi.org/10.1002/cncr.20755
Delaney G; Jacob S; Barton M, 2004, 'Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: Part II - Carcinoma of the endometrium', Cancer, vol. 101, pp. 682 - 692, http://dx.doi.org/10.1002/cncr.20445
Delaney G; Jacob S; Barton M, 2004, 'Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: Part I - Malignancies of the cervix, ovary, vagina, and vulva', Cancer, vol. 101, pp. 671 - 681, http://dx.doi.org/10.1002/cncr.20444
Delaney GP; Barton MB; Jacobs S, 2004, 'Estimation of an optimal radiotherapy utilization rate for gastro-intstinal carcinoma: a review of evidence', Cancer, vol. 101/4, pp. 657 - 670, http://dx.doi.org/10.1002/cncr.20443
Delaney GP; Barton MB; Jacobs S, 2004, 'Estimation of optimal radiotherapy utilization rate for melanoma: a review of the evidence.', Cancer, vol. 15, pp. 1293 - 1301, http://dx.doi.org/10.1002/cncr.20092
Delaney GP; Barton MB; Jacobs S, 2003, 'Estimation of an optimal radiotherapy utilization rate for breast carcinoma', Cancer, vol. 98, pp. 1977 - 1986, http://dx.doi.org/10.1002/cncr.11740
Barton MB; Dawson R; Jacob S; Currow DC; Stevens G; Morgan GJ, 2001, 'Palliative radiotherapy of bone metastases: an evaluation of outcome measures', Journal of Evaluation in Clinical Practice, vol. 7, pp. 47 - 64, http://dx.doi.org/10.1046/j.1365-2753.2001.00262.x
Perera S; Barton M; Jacob S, 2018, 'Benchmarking the optimum surgical utilisation rate for common gastrointestinal tumours in Australia', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 101 - 101, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449544200134&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Jacob SA; Bokey EL; Wong K; Delaney GP; Barton MB, 2017, 'The Role of Surgery in Colorectal Cancer Treatment Defined by a Benchmark Rate of Optimal Surgical Utilisation', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 191 - 192, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413954500319&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Do V; Ng W; Jacob S; Delaney GP; Barton M, 2017, 'An estimation of the population survival benefit of first-course chemotherapy for head and neck cancers', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Madrid, SPAIN, presented at 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, SPAIN, 08 September 2017 - 12 September 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000411324002275&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Wilson BE; Jacob S; Barton MB, 2019, 'Global demands for chemotherapy, HER-2 and endocrine therapy for breast cancer using NCCN resource stratified guidelines', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 15, pp. 153 - 154, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400235&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Perera SK; Barton M; Jacob S, 2019, 'Optimum surgical utilisation rates for urological cancers in Australia', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 15, pp. 120 - 120, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400159&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Jacob S; Ng W; Do V; Wilson B; Barton M, 2018, 'The effect of changes in indications for chemotherapy on the optimal chemotherapy utilisation rate in early breast cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 14, pp. 115 - 115, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449544200165&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Do V; Ng W; Jacob S; Delaney G; Barton M, 2018, 'An estimation of the population-based survival benefit of first-course chemotherapy for advanced incurable cancer', in Annals of oncology : official journal of the European Society for Medical Oncology, OXFORD UNIV PRESS, Singapore, SINGAPORE, Vol. 29, pp. ix111, presented at European-Society-for-Medical-Oncology Asia Congress, Singapore, SINGAPORE, 23 November 2018 - 25 November 2018, http://dx.doi.org/10.1093/annonc/mdy440.006
Jacob S; Hovey E; Vinod S; Delaney G; Barton M, 2007, 'Estimation of an optimal chemotherapy utilisation rate for lung cancer', in EJC SUPPLEMENTS, PERGAMON-ELSEVIER SCIENCE LTD, Barcelona, SPAIN, Vol. 5, pp. 165 - 166, presented at 14th European Cancer Conference (ECCO 14), Barcelona, SPAIN, 23 September 2007 - 27 September 2007, http://dx.doi.org/10.1016/S1359-6349(07)70698-5
CRICOS Provider Code: 00D98G
ABN 57 195 873 179
T +61 (2) 8738 3844
F +61 (2) 8738 3850
E swsydunsw@unsw.edu.au
UNSW, Liverpool Hospital
Locked Bag 7103
LIVERPOOL BC NSW 1871
Australia
Level 2, Education Building
Liverpool Hospital
Cnr Elizabeth/Goulburn Sts
LIVERPOOL NSW 2170
Australia
Copyright © 2014 UNSW MEDICINE - South Western Sydney Clinical School
Authorised by South Western Sydney Clinical School - Page Last Updated:
16:12:27 PM, Friday 26 February 2021